← Back to Clinical Trials
Recruiting NCT06104059

NCT06104059 NOL Guided Analgesia During Elective Laparoscopic Surgery Under General Anesthesia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06104059
Status Recruiting
Phase
Sponsor Attikon Hospital
Condition Intraoperative Analgesia
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2023-04-20
Primary Completion 2025-09-20

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 70 Years
Study Type INTERVENTIONAL
Interventions
Nociception level index (NOL™)Fentanyl

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2023-04-20 with a primary completion date of 2025-09-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to investigate the hypothesis that the intraoperative use of the nociception level index NOL can reduce opioid consumption in adult patients undergoing elective laparoscopic surgeries under general anesthesia, as well as to explore its effect on post-operative pain and patient recovery.

Eligibility Criteria

Inclusion Criteria: * Adult patients undergoing planned laparoscopic surgery under general anesthesia. Exclusion Criteria: * Emergency surgery. * Pregnancy. * Drug or alcohol abuse in the last 6 months. * Chronic opioid use or patients with chronic pain. * Serious comorbidity \[cardiac disease (atrial fibrillation, ventricular arrhythmias), liver or kidney disease\] * Obesity (BMI \>35). * Permanently implanted pacemaker. * Patients with CNS disease. * Allergy to any of the study drugs. * Patients receiving anticholinergics agonists, α2-adrenergic agonists, β1-adrenergic antagonists, antiarrhythmic drugs.

Contact & Investigator

Central Contact

PARASKEVI Prof MATSOTA

✉ matsota@yahoo.gr

📞 6945544563

Frequently Asked Questions

Who can join the NCT06104059 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Intraoperative Analgesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06104059 currently recruiting?

Yes, NCT06104059 is actively recruiting participants. Contact the research team at matsota@yahoo.gr for enrollment information.

Where is the NCT06104059 trial being conducted?

This trial is being conducted at Athens, Greece.

Who is sponsoring the NCT06104059 clinical trial?

NCT06104059 is sponsored by Attikon Hospital. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology